Restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: a multicenter case-controlled study

2017 ◽  
Vol 40 ◽  
pp. e320
Author(s):  
K. Suzuki ◽  
Y. Okuma ◽  
T. Uchiyama ◽  
M. Miyamoto ◽  
R. Sakakibara ◽  
...  
2017 ◽  
Vol 44 ◽  
pp. 18-22 ◽  
Author(s):  
Keisuke Suzuki ◽  
Yasuyuki Okuma ◽  
Tomoyuki Uchiyama ◽  
Masayuki Miyamoto ◽  
Ryuji Sakakibara ◽  
...  

2003 ◽  
Vol 18 (2) ◽  
pp. 181-185 ◽  
Author(s):  
Pudukode R. Krishnan ◽  
Manvir Bhatia ◽  
Madhuri Behari

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Keisuke Suzuki ◽  
Masayuki Miyamoto ◽  
Tomoyuki Miyamoto ◽  
Koichi Hirata

Sleep disturbances are important nonmotor symptoms in Parkinson’s disease (PD) that are associated with a negative impact on quality of life. Restless legs syndrome (RLS), which is characterized by an urge to move the legs accompanied by abnormal leg sensations, can coexist with PD, although the pathophysiology of these disorders appears to be different. RLS and PD both respond favorably to dopaminergic treatment, and several investigators have reported a significant relationship between RLS and PD. Sensory symptoms, pain, motor restlessness, akathisia, and the wearing-off phenomenon observed in PD should be differentiated from RLS. RLS in PD may be confounded by chronic dopaminergic treatment; thus, more studies are needed to investigate RLS in drug-naïve patients with PD. Recently, leg motor restlessness (LMR), which is characterized by an urge to move the legs that does not fulfill the diagnostic criteria for RLS, has been reported to be observed more frequently in de novo patients with PD than in age-matched healthy controls, suggesting that LMR may be a part of sensorimotor symptoms intrinsic to PD. In this paper, we provide an overview of RLS, LMR, and PD and of the relationships among these disorders.


2018 ◽  
Vol 393 ◽  
pp. 51-57 ◽  
Author(s):  
Takeo Matsubara ◽  
Keisuke Suzuki ◽  
Hiroaki Fujita ◽  
Yuji Watanabe ◽  
Hirotaka Sakuramoto ◽  
...  

2017 ◽  
Vol 40 ◽  
pp. e92-e93
Author(s):  
A. Marques ◽  
M. Figorilli ◽  
B. Pereira ◽  
P. Beudin ◽  
T. Vidal ◽  
...  

2010 ◽  
Vol 25 (13) ◽  
pp. 2142-2147 ◽  
Author(s):  
Dagmar Verbaan ◽  
Stephanie M. van Rooden ◽  
Jacobus J. van Hilten ◽  
Roselyne M. Rijsman

2018 ◽  
Vol 76 (11) ◽  
pp. 731-735 ◽  
Author(s):  
Maren de Moraes e Silva ◽  
Cezar Henrique Lorenzi ◽  
Blenda Barreto Schneider ◽  
Catherine Enk Fischer Seidel ◽  
Isabela Salomé ◽  
...  

ABSTRACT Restless legs syndrome (RLS) is a disorder commonly found in patients with Parkinson's disease, with descriptions for both conditions impairing dopaminergic transmission in central nervous system. Previous studies in varied populations indicate an association between the presence of RLS and increased cardiovascular risk and, so far, there are no consistent studies of this association in Parkinson's disease. Objective: To analyze the influence of RLS on cardiovascular risk in patients with Parkinson's disease. Methods: We reviewed the medical records of 202 patients diagnosed with Parkinson's disease and verified the presence of RLS, cardiovascular comorbidities, blood pressure measurements, lipid profiles and Framingham Risk Scores. Results: Statistically significant higher values of total cholesterol were found for the RLS group (mean 216.6 mg/dL), as well as for LDL cholesterol (mean 145 mg/dL). No statistical difference was found among the other factors. Conclusion: Patients with Parkinson's disease and RLS have a higher prevalence of dyslipidemia than patients without RLS, suggesting a correlation between restless legs and hyperlipidemia. It is questioned whether the dopaminergic substrate is the main factor in the genesis of the syndrome, as even with the use of dopaminergic agonists by both groups, it was possible to observe differences between groups. The hypothesis of the real interference of the syndrome treatment as a protective factor for cardiovascular risk was generated.


Sign in / Sign up

Export Citation Format

Share Document